 |
|
|
| |
A Decision-Analytic Markov Model to Evaluate the Health Outcomes of Ledipasvir/Sofosbuvir for Patients with Chronic Hepatitis C Genotype 1 Infection
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Zobair M Younossi1,2, Sammy Saab3, Aijaz Ahmed4, Stuart C. Gordon5
1Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA; 2.Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA; 3.University of California Los Angeles, Los Angeles, CA; 4.Stanford University, Stanford, CA; 5.Henry Ford Hospital, Detroit, MI
|
| |
|
|
|
|
|
